Clinical Trials and Unfavorable Results

This post on Chilmark Research discusses how the pharmaceutical industry has an uncharacteristic practice of sequestering less than favorable results. According to the post, approximately 75 percent of research never sees the light of day due to unfavorable results. Read the full article here.